ONCORENA AB has a total of 11 patent applications. Its first patent ever was published in 2009. It filed its patents most often in China, EPO (European Patent Office) and Hong Kong. Its main competitors in its focus markets pharmaceuticals are MENDOZA WENDELL G, EMBERA NEUROTHERAPEUTICS INC and FK SLAVYANSKAYA APTEKA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Hong Kong | 2 | |
#4 | Canada | 1 | |
#5 | Japan | 1 | |
#6 | Republic of Korea | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nilsson Ulf | 7 |
#2 | Buvall Lisa | 7 |
#3 | Nystroem Jenny | 5 |
#4 | Ulf Nilsson | 4 |
#5 | Haraldsson Boerje | 4 |
#6 | Lisa Buvall | 4 |
#7 | Boerje Haraldsson | 3 |
#8 | Jenny Nystroem | 3 |
#9 | Haraldsson Borje | 2 |
#10 | Brje Haraldsson | 1 |
Publication | Filing date | Title |
---|---|---|
EP2552443A1 | Improved treatment of renal cell carcinoma | |
EP2349268A1 | 3, 3', 4, 4'-tetrahydroxy-2, 2'-bipyridine-n, n'-dioxides for the treatment of renal cell carcinoma |